Jacob J. Adashek - Search Results

Year	Number of Results
2018	4
2019	14
2020	17
2021	16
2022	13
2023	17
2024	6

1

SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy.

Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R. Mardinian K, et al. Among authors: adashek jj. Mol Cancer Ther. 2021 Dec;20(12):2341-2351. doi: 10.1158/1535-7163.MCT-21-0433. Epub 2021 Oct 12. Mol Cancer Ther. 2021. PMID: 34642211 Free PMC article. Review.

2

Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review.

Desai AP, Adashek JJ, Reuss JE, West HJ, Mansfield AS. Desai AP, et al. Among authors: adashek jj. JAMA Oncol. 2023 Jan 1;9(1):135-142. doi: 10.1001/jamaoncol.2022.5389. JAMA Oncol. 2023. PMID: 36394834 Review.

3

Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload.

Kondrashov A, Sapkota S, Sharma A, Riano I, Kurzrock R, Adashek JJ. Kondrashov A, et al. Among authors: adashek jj. Pharmaceutics. 2023 Aug 19;15(8):2160. doi: 10.3390/pharmaceutics15082160. Pharmaceutics. 2023. PMID: 37631374 Free PMC article. Review.

4

Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?

Gupta A, Kurzrock R, Adashek JJ. Gupta A, et al. Among authors: adashek jj. Cancers (Basel). 2023 Mar 3;15(5):1578. doi: 10.3390/cancers15051578. Cancers (Basel). 2023. PMID: 36900367 Free PMC article. Review.

5

Adjuvant treatment in renal cell carcinoma.

Dizman N, Adashek JJ, Hsu J, Bergerot PG, Bergerot CD, Pal SK. Dizman N, et al. Among authors: adashek jj. Clin Adv Hematol Oncol. 2018 Aug;16(8):555-563. Clin Adv Hematol Oncol. 2018. PMID: 30148828 Review.

6

Considering molecular alterations as pan-cancer tissue-agnostic targets.

Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R. Adashek JJ, et al. Nat Cancer. 2023 Dec;4(12):1622-1626. doi: 10.1038/s43018-023-00676-y. Nat Cancer. 2023. PMID: 38102355 No abstract available.

7

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

Adashek JJ, Subbiah IM, Matos I, Garralda E, Menta AK, Ganeshan DM, Subbiah V. Adashek JJ, et al. Trends Cancer. 2020 Mar;6(3):181-191. doi: 10.1016/j.trecan.2020.01.005. Epub 2020 Feb 6. Trends Cancer. 2020. PMID: 32101722 Free PMC article. Review.

8

Genomics and Immunomics in the Treatment of Urothelial Carcinoma.

Mollica V, Massari F, Rizzo A, Ferrara R, Menta AK, Adashek JJ. Mollica V, et al. Among authors: adashek jj. Curr Oncol. 2022 May 12;29(5):3499-3518. doi: 10.3390/curroncol29050283. Curr Oncol. 2022. PMID: 35621673 Free PMC article. Review.

9

Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics.

Tateo V, Marchese PV, Mollica V, Massari F, Kurzrock R, Adashek JJ. Tateo V, et al. Among authors: adashek jj. Pharmaceuticals (Basel). 2023 Apr 19;16(4):614. doi: 10.3390/ph16040614. Pharmaceuticals (Basel). 2023. PMID: 37111371 Free PMC article. Review.

10

Cancer Genetics and Therapeutic Opportunities in Urologic Practice.

Adashek JJ, Leonard A, Roszik J, Menta AK, Genovese G, Subbiah V, Msaouel P. Adashek JJ, et al. Cancers (Basel). 2020 Mar 18;12(3):710. doi: 10.3390/cancers12030710. Cancers (Basel). 2020. PMID: 32197306 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year